Stocks › LCTX
Lineage Cell Therapeutics, Inc.
LCTX·NYSE·
United States·USD
United States·USD$0.94
+0.01 (+1.13%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
LCTX
Lineage Cell Therapeutics, Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
LCTXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of LCTX by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Anna Paulina LunaHouse · R · FL |
LCTXLineage Cell Therapeutics, Inc. · Stock |
Purchase $1,001 - $15,000 |
Jan 29, 2024 | Jan 4, 2024 | Filing ↗ |
Whale Activity
Position changes in LCTX reported for 2026-09-30 by 1 tracked institutional filer
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| Defender Capital, LLC. | 6.6M | $6.4M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by LCTX insiders, by quarter · Form 4
Recent Insider Transactions
102 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Culley Brian MPresident and CEO · Director | Purchase | +15.0K | $1.63 | $24K | Mar 12, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Tax withholding | −12.9K | $1.80 | $23K | Feb 11, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Option exercise | +31.3K | — | — | Feb 11, 2026 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Tax withholding | −2,502 | $1.80 | $5K | Feb 11, 2026 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Option exercise | +6,075 | — | — | Feb 11, 2026 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Tax withholding | −334 | $1.68 | $561 | Dec 19, 2025 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Grant / award | +8,925 | — | — | Dec 19, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Tax withholding | −65 | $1.68 | $109 | Dec 19, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel and Secretary | Grant / award | +1,735 | — | — | Dec 19, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel | Tax withholding | −2,440 | $0.65 | $2K | Feb 11, 2025 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel | Option exercise | +6,076 | — | — | Feb 11, 2025 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Tax withholding | −12.5K | $0.65 | $8K | Feb 11, 2025 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Option exercise | +31.2K | — | — | Feb 11, 2025 | Form 4 ↗ |
| BROADWOOD CAPITAL INC10% owner | Purchase | +0 | $0.00 | $0 | Jan 27, 2025 | Form 4 ↗ |
| BROADWOOD CAPITAL INC10% owner | Purchase | +7.9M | n/c | — | Jan 27, 2025 | Form 4 ↗ |
| Howe Jill AnnChief Financial Officer | Purchase | +15.0K | $0.59 | $9K | Nov 26, 2024 | Form 4 ↗ |
| Samuel George A. IIIGeneral Counsel | Purchase | +15.0K | $0.60 | $9K | Nov 26, 2024 | Form 4 ↗ |
| Mulroy Michael H.Director | Purchase | +40.0K | $0.57 | $23K | Nov 22, 2024 | Form 4 ↗ |
| Culley Brian MPresident and CEO · Director | Purchase | +40.0K | $0.60 | $24K | Nov 21, 2024 | Form 4 ↗ |
| Howe Jill AnnChief Financial Officer | Purchase | +10.5K | $0.89 | $9K | Aug 16, 2024 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding LCTX · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5.9M | $7.7M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 4.2M | $5.4M | 0.01% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.0M | $3.9M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 1.7M | $2.3M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 2.0M | $2.2M | 0.01% | Jul 31, 2026 |
| iShares Biotechnology ETF iShares Trust | 1.3M | $1.7M | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 1.2M | $1.6M | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF iShares Trust | 617.2K | $808K | 0.05% | Jun 30, 2026 |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 438.4K | $583K | 0.00% | May 31, 2026 |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 447.5K | $483K | 0.01% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list LCTX's shares (CUSIP 53566P109), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- BlackRock, Inc.SCHEDULE 13G · passive (13G) · 13.2M shares5.3%
Jul 29, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Lineage Cell Therapeutics, Inc. as client
No lobbying filings found naming Lineage Cell Therapeutics, Inc. as the client.
Government Contracts
Federal awards to Lineage Cell Therapeutics, Inc. · USAspending
No federal contract awards found for Lineage Cell Therapeutics, Inc..
U.S. Patents
Recent USPTO applications naming Lineage Cell Therapeutics, Inc.
No USPTO patent applications found for Lineage Cell Therapeutics, Inc..
Annual Financials
From LCTX's 10-K filings · XBRL
No annual XBRL figures on record for LCTX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 8-for-7Stock splitNov 29, 2018
- 13-for-12Stock splitJan 4, 2016
- 3-for-1Stock splitOct 31, 1997
Split dates and ratios from the price history · Close Prices from Tiingo.com
About Lineage Cell Therapeutics, Inc.
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersCARLSBAD, CA
IncorporatedCA
SEC CIK0000876343 ↗
Former namesBIOTIME INC